We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Molecular Trojan Horse Delivers Chemo Drug to Cancer Cells

News   Feb 26, 2018 | Original story from University of California, Riverside

 
Molecular Trojan Horse Delivers Chemo Drug to Cancer Cells

Schematic illustration of the developed cancer targeting agent -- 123B9 in this study. The compound (right panel) has a scorpion-like shape with two arms grabbing EphA2-expressing cancer cells, and a tail (brown) constituted by a cytotoxic chemotherapeutic agent (paclitaxel used in this work). The agent would recognize the surface of cancer cells rich in EphA2 (labeled in red in the left panel which shows cancer cells) and deliver the cytotoxic agent. Credit: Pellecchia lab, UC Riverside.

 
 
 

RELATED ARTICLES

Imaging Tumor Stiffness To Enhance Breast and Pancreatic Cancer Treatments

News

Using a non-invasive imaging technique that measures the stiffness of tissues gives vital new information about cancer architecture and could aid the delivery of treatment to challenging tumors.

READ MORE

Novel Strategy for Synthesizing Complex Natural Products

News

Scientists have succeeded in synthesizing two complex products from a group which could be used in the development of new drugs.

READ MORE

“Sticky” Gene Could Help Valium Calm Nerves

News

Scientists have discovered that Valium and other benzodiazepines may need the assistance of a "sticky" gene, named after a mythological figure, called Shisa7, to "calm" nerves.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE